comparemela.com

Latest Breaking News On - Utah drug information - Page 2 : comparemela.com

Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research

Indian drugmakers, which have the U.S. market as a key segment, will sustain their revenue improvement in fiscal 2025 due to drug shortages in the United States, Mumbai-based India Ratings and.

Dr Reddy s, Cipla, Sun Pharma & others to see FY25 revenue boost in key US market, says India Ratings and Research

Indian drugmakers, such as Dr Reddy s, Cipla, and Sun Pharma, are projected to maintain revenue growth in fiscal 2025, driven by drug shortages in the U.S. market. With 233 drugs in short supply, Indian companies are poised to benefit from the challenges faced by U.S.-based generic pharma manufacturers, leading to improved financial performance and increased market share in therapeutic categories.

Health: Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research

Health: Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.